Picture of Axsome Therapeutics logo

AXSM — Axsome Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapFalling Star

US FDA approves Axsome Therapeutics' migraine drug

Jan 30 (Reuters) - The U.S. Food and Drug Administration
has approved Axsome Therapeutics'  AXSM.O  migraine treatment,
the company said on Thursday.  

 (Reporting by Mariam Sunny in Bengaluru; Editing by Maju
Samuel)
 ((Mariam.ESunny@thomsonreuters.com;))

Recent news on Axsome Therapeutics

See all news